© Copyright 2013, vLex. All Rights Reserved.
- Language
Contents in vLex United States
Explore vLex
For Professionals
For Partners
Company
Biotech Financial Reports
COPYRIGHT TV Trade Media, Inc.
COPYRIGHT GALE, Cengage Learning. All rights reserved.
COPYRIGHT GALE, Cengage Learning. All rights reserved
from July 1998
Last Number: June 2012
All the contents
Year 2010
ADVAXIS APPROVED TO SELL BOUT $300,000 WORTH OF LOSSES/CREDITS.
BARDA AWARDS UP TO $143 MIL FOR DEVELOPMENT OF ANTHRAX DRUG.
United States. Biomedical Advanced Research and Development Agency - EluSys Therapeutics Inc.